• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    argenx SE - American Depositary Shares (NQ:ARGX)

    699.72 -9.13 (-1.29%)
    Streaming Delayed Price Updated: 12:29 PM EDT, Mar 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 136,826
    Open 710.50
    Bid (Size) 699.81 (40)
    Ask (Size) 700.35 (80)
    Prev. Close 708.85
    Today's Range 694.14 - 713.64
    52wk Range 510.06 - 934.62
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough
    Date: March 12, 2026 Introduction Dianthus Therapeutics (NASDAQ: DNTH) has become the center of Wall Street’s attention today, with its share price surging 19.4% in early trading following a pivotal... 
    Via Finterra
    Topics Economy
    News headline image
    DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch ↗
    Dianthus Therapeutics announced an early “go” decision for its experimental drug claseprubart in its Chronic Inflammatory Demyelinating Polyneuropathy program based on analysis of data from a part of... 
    Via Stocktwits

    Performance

    YTD
    -16.7%
    -16.7%
    1 Month
    -16.0%
    -16.0%
    3 Month
    -21.3%
    -21.3%
    6 Month
    -8.4%
    -8.4%
    1 Year
    +18.3%
    +18.3%

    More News

    Read More
    News headline image
    argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
    From argenx SE
    Via GlobeNewswire
    News headline image
    Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability
    Via Finterra
    Topics Earnings Economy Intellectual Property
    News headline image
    argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx to Present at TD Cowen 46th Annual Healthcare Conference
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
    From argenx SE
    Via GlobeNewswire
    News headline image
    Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗
    Via The Motley Fool
    News headline image
    Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗
    Via The Motley Fool
    News headline image
    Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
    Via Finterra
    Topics ETFs Economy Initial Public Offering
    News headline image
    argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx Highlights 2026 Strategic Priorities
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx Announces Leadership Transition Marking Next Evolution of Growth
    From argenx SE
    Via GlobeNewswire
    News headline image
    Beyond the Bot: 2026 Marks the Great Rebalancing as Investors Pivot from AI Hype to Tangible Growth
    Via MarketMinute
    Topics Artificial Intelligence Economy
    News headline image
    The 2026 Horizon: Technical Breakouts Signal a Sustained Bull Run in AI and Energy
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Biohaven Ltd. (BHVN): A High-Stakes Clinical Crossroad in Neuroscience and Immunology
    Via PredictStreet
    Topics Economy Intellectual Property
    News headline image
    argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
    From argenx SE
    Via GlobeNewswire
    News headline image
    ARGENX SE (NASDAQ:ARGX) Combines Minervini Trend Strength with Explosive Fundamental Growth ↗
    Via Chartmill
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    Via Benzinga
    News headline image
    $1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today ↗
    Via Benzinga
    News headline image
    argenx Announces Results of Extraordinary General Meeting of Shareholders
    From argenx SE
    Via GlobeNewswire

    Frequently Asked Questions

    Is argenx SE - American Depositary Shares publicly traded?
    Yes, argenx SE - American Depositary Shares is publicly traded.
    What exchange does argenx SE - American Depositary Shares trade on?
    argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for argenx SE - American Depositary Shares?
    The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
    What is the current price of argenx SE - American Depositary Shares?
    The current price of argenx SE - American Depositary Shares is 699.72
    When was argenx SE - American Depositary Shares last traded?
    The last trade of argenx SE - American Depositary Shares was at 03/13/26 12:29 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.